|
TVIS20024173
|
Human Papillomavirus |
HPV16 |
K02718 |
58 |
- |
hg38 |
chr17 |
38450812 |
38450812 |
q12 |
ARHGAP23, ENSG00000276170 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024174
|
Human Papillomavirus |
HPV16 |
K02718 |
1458 |
- |
hg38 |
chr16 |
34581453 |
34581453 |
p11.2 |
- |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024175
|
Human Papillomavirus |
HPV16 |
K02718 |
1740 |
- |
hg38 |
chr8 |
127804488 |
127804488 |
q24.21 |
PVT1 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024176
|
Human Papillomavirus |
HPV16 |
K02718 |
1840 |
- |
hg38 |
chr9 |
28600296 |
28600296 |
p21.1 |
LINGO2 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024177
|
Human Papillomavirus |
HPV16 |
K02718 |
6845 |
- |
hg38 |
chr14 |
99263966 |
99263966 |
q32.2 |
ENSG00000235785, BCL11B |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024178
|
Human Papillomavirus |
HPV16 |
K02718 |
2219 |
- |
hg38 |
chr18 |
3446551 |
3446551 |
p11.31 |
TGIF1, ENSG00000302876 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024179
|
Human Papillomavirus |
HPV16 |
K02718 |
4630 |
- |
hg38 |
chr7 |
48768247 |
48768247 |
p12.3 |
- |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024180
|
Human Papillomavirus |
HPV16 |
K02718 |
1138 |
- |
hg38 |
chr8 |
127724539 |
127724539 |
q24.21 |
CASC11 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024181
|
Human Papillomavirus |
HPV16 |
K02718 |
951 |
- |
hg38 |
chr14 |
98722711 |
98722711 |
q32.2 |
- |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024182
|
Human Papillomavirus |
HPV16 |
K02718 |
637 |
- |
hg38 |
chr7 |
48880518 |
48880518 |
p12.3 |
ENSG00000299032 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |